Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy

Although radiation therapy (RT) is one of the mainstays of head and neck cancer (HNC) treatment, innovative approaches are needed to further improve treatment outcomes. A significant challenge has been to design delivery strategies that focus high doses of radiation on the tumor tissue while minimiz...

Full description

Bibliographic Details
Main Authors: Poornima Dubey, Mathieu Sertorio, Vinita Takiar
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/3/514
_version_ 1797488838542622720
author Poornima Dubey
Mathieu Sertorio
Vinita Takiar
author_facet Poornima Dubey
Mathieu Sertorio
Vinita Takiar
author_sort Poornima Dubey
collection DOAJ
description Although radiation therapy (RT) is one of the mainstays of head and neck cancer (HNC) treatment, innovative approaches are needed to further improve treatment outcomes. A significant challenge has been to design delivery strategies that focus high doses of radiation on the tumor tissue while minimizing damage to surrounding structures. In the last decade, there has been increasing interest in harnessing high atomic number materials (Z-elements) as nanoparticle radiosensitizers that can also be specifically directed to the tumor bed. Metallic nanoparticles typically display chemical inertness in cellular and subcellular systems but serve as significant radioenhancers for synergistic tumor cell killing in the presence of ionizing radiation. In this review, we discuss the current research and therapeutic efficacy of metal nanoparticle (MNP)-based radiosensitizers, specifically in the treatment of HNC with an emphasis on gold- (AuNPs), gadolinium- (AGdIX), and silver- (Ag) based nanoparticles together with the metallic oxide-based hafnium (Hf), zinc (ZnO) and iron (SPION) nanoparticles. Both in vitro and in vivo systems for different ionizing radiations including photons and protons were reviewed. Finally, the current status of preclinical and clinical studies using MNP-enhanced radiation therapy is discussed.
first_indexed 2024-03-10T00:08:00Z
format Article
id doaj.art-43e4ea2393f44d2a93dfc88e540f28c7
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T00:08:00Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-43e4ea2393f44d2a93dfc88e540f28c72023-11-23T16:04:05ZengMDPI AGCancers2072-66942022-01-0114351410.3390/cancers14030514Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer TherapyPoornima Dubey0Mathieu Sertorio1Vinita Takiar2Department of Radiation Oncology, University of Cincinnati Barrett Cancer Center, 234 Goodman Street, ML 0757, Cincinnati, OH 45267, USADepartment of Radiation Oncology, University of Cincinnati Barrett Cancer Center, 234 Goodman Street, ML 0757, Cincinnati, OH 45267, USADepartment of Radiation Oncology, University of Cincinnati Barrett Cancer Center, 234 Goodman Street, ML 0757, Cincinnati, OH 45267, USAAlthough radiation therapy (RT) is one of the mainstays of head and neck cancer (HNC) treatment, innovative approaches are needed to further improve treatment outcomes. A significant challenge has been to design delivery strategies that focus high doses of radiation on the tumor tissue while minimizing damage to surrounding structures. In the last decade, there has been increasing interest in harnessing high atomic number materials (Z-elements) as nanoparticle radiosensitizers that can also be specifically directed to the tumor bed. Metallic nanoparticles typically display chemical inertness in cellular and subcellular systems but serve as significant radioenhancers for synergistic tumor cell killing in the presence of ionizing radiation. In this review, we discuss the current research and therapeutic efficacy of metal nanoparticle (MNP)-based radiosensitizers, specifically in the treatment of HNC with an emphasis on gold- (AuNPs), gadolinium- (AGdIX), and silver- (Ag) based nanoparticles together with the metallic oxide-based hafnium (Hf), zinc (ZnO) and iron (SPION) nanoparticles. Both in vitro and in vivo systems for different ionizing radiations including photons and protons were reviewed. Finally, the current status of preclinical and clinical studies using MNP-enhanced radiation therapy is discussed.https://www.mdpi.com/2072-6694/14/3/514head and neck cancer (HNC)radiosensitizermetal nanoparticle (MNP)metal oxide nanoparticleclinical translationnanoparticles
spellingShingle Poornima Dubey
Mathieu Sertorio
Vinita Takiar
Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy
Cancers
head and neck cancer (HNC)
radiosensitizer
metal nanoparticle (MNP)
metal oxide nanoparticle
clinical translation
nanoparticles
title Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy
title_full Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy
title_fullStr Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy
title_full_unstemmed Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy
title_short Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy
title_sort therapeutic advancements in metal and metal oxide nanoparticle based radiosensitization for head and neck cancer therapy
topic head and neck cancer (HNC)
radiosensitizer
metal nanoparticle (MNP)
metal oxide nanoparticle
clinical translation
nanoparticles
url https://www.mdpi.com/2072-6694/14/3/514
work_keys_str_mv AT poornimadubey therapeuticadvancementsinmetalandmetaloxidenanoparticlebasedradiosensitizationforheadandneckcancertherapy
AT mathieusertorio therapeuticadvancementsinmetalandmetaloxidenanoparticlebasedradiosensitizationforheadandneckcancertherapy
AT vinitatakiar therapeuticadvancementsinmetalandmetaloxidenanoparticlebasedradiosensitizationforheadandneckcancertherapy